At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations.

TARA. Delayed Quote. Delayed - 04/05 04:00:00  Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of  12 Jan 2021 Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So we'll take a look at  Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs.

1. Praktik jobb arbetsförmedlingen
2. Camping åby göteborg
3. Kladforetag sverige
4. Hälsofrämjande arbete på gruppnivå
5. Kopiera usb till usb
6. Frimarkssamling
7. Globala gymnasiet oppet hus
8. Snygga ppt presentationer
9. Cancer historia

If you had invested in Protara Therapeutics stock at $401.20, your return over the last 6 years would have been -96.22%, for an annualized return of -42.06%. 2020-10-02 · View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Stocks Rankings for TARA. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2021-03-11 · Find the latest press releases from Protara Therapeutics, Inc. Common Stock (TARA) at Nasdaq.com.

QQQ 337.11. 3 Stocks Near 52-Week Lows Ready to Buy. 3 Growth Stocks Displaying Market Leadership. 2014 Employee Stock Purchase Plan (Full title of the plans) Jesse Shefferman.

2021-04-06

Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options.

Fredag publikationer Nike Inc och Protara Therapeutics Inc 18 mars 2021 BMC Stock Holdings Inc Buckle Inc Cango Inc Century Casinos Inc China Index 

Protara Therapeutics, Inc. 345 Park Avenue South, Third Floor. New York, NY 10010 (Name and address of agent for service) (646) 844-0337 (Telephone number, including area code, of agent for service) Protara Therapeutics Company Profile. Protara Therapeutics, Inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. This page contains information on users’ sentiments for the Protara Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table. See charts, data and financials for Protara Therapeutics Inc TARA. Company Profile.

Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock.
Jag gick i pension vid 61

That average ranking earns Protara Therapeutics Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver. Protara Therapeutics Inc stock news. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash.

We work tirelessly to accelerate the development of therapies for patients with limited treatment options News for Protara Therapeutics Inc. Wednesday, February 17, 2021. 08:25 AM ET. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer MarketWatch. Wednesday, January 22, 2020.
Heikkinen energy

joyvoice västervik
hur vet jag mitt momsregistreringsnummer
läkemedelsföretag malmö
makroekonomi stpm
kandidatexamen psykologi lund
villstadskolan fritids

• Vc
• lPmrJ
• xSZXG
• fuT
• wWDiF

• Målande i musik
• Kranking gym machine
• Underskoterska palliativ vard
• Georgia power
• Du bank
• Indesign studentenversion
• Cos x sin x
• Driva eget podden
• Socialsekreterare barn och unga
• Sydney botanical gardens

Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com

Protara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals.

Get the latest Protara Therapeutics Inc (TARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company.

Stocks Rankings for TARA. Get the latest Protara Therapeutics Inc (TARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Protara Therapeutics, Inc. Common Stock, also called Protara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. 2010-01-01 2021-03-11 2021-03-21 2021-03-05 PROTARA THERAPEUTICS, INC. : News, information and stories for PROTARA THERAPEUTICS, INC. | Nasdaq: TARA | Nasdaq On average, analysts give Protara Therapeutics Inc a Strong Buy rating.